Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ganshorn is a Germany-based pulmonary diagnostics and medical device company focused on lung function testing systems for hospitals, clinics, and pulmonary practices. The company develops and manufactures commercial pulmonary function testing equipment spanning spirometry, body plethysmography, diffusion testing, oscillometry, broncho-provocation, and cardiopulmonary exercise testing. Its core differentiator is calibration-free ultrasound flow measurement technology, marketed under the SharpFlow platform and used in products such as SpiroScout and the PowerCube family. Ganshorn is part of the SCHILLER Group, reflecting a strategic combination of pulmonary and cardiopulmonary diagnostics capabilities. The business is healthcare-related but not a therapeutics developer, so it does not have a drug pipeline in the biotech or pharma sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ganshorn.